DE60009704D1 - Zusammensetzung zur vorbeugung von muskulärer erschöpfung und zur anpassung von skelettmuskel an intensive körperliche anstrengung - Google Patents

Zusammensetzung zur vorbeugung von muskulärer erschöpfung und zur anpassung von skelettmuskel an intensive körperliche anstrengung

Info

Publication number
DE60009704D1
DE60009704D1 DE60009704T DE60009704T DE60009704D1 DE 60009704 D1 DE60009704 D1 DE 60009704D1 DE 60009704 T DE60009704 T DE 60009704T DE 60009704 T DE60009704 T DE 60009704T DE 60009704 D1 DE60009704 D1 DE 60009704D1
Authority
DE
Germany
Prior art keywords
adapting
exhaust
composition
physical stress
intensive physical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60009704T
Other languages
English (en)
Other versions
DE60009704T2 (de
Inventor
Claudio Cavazza
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sigma Tau Industrie Farmaceutiche Riunite SpA
Original Assignee
Sigma Tau Industrie Farmaceutiche Riunite SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Industrie Farmaceutiche Riunite SpA filed Critical Sigma Tau Industrie Farmaceutiche Riunite SpA
Application granted granted Critical
Publication of DE60009704D1 publication Critical patent/DE60009704D1/de
Publication of DE60009704T2 publication Critical patent/DE60009704T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nutrition Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Plant Substances (AREA)
DE60009704T 1999-07-23 2000-07-21 Zusammensetzung zur vorbeugung von muskulärer erschöpfung und zur anpassung von skelettmuskel an intensive körperliche anstrengung Expired - Lifetime DE60009704T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT1999RM000467A IT1306173B1 (it) 1999-07-23 1999-07-23 Composizione per la prevenzione degli affaticamenti muscolari e permigliorare il rendimento energetico muscolare.
ITRM990467 1999-07-23
PCT/IT2000/000308 WO2001006873A1 (en) 1999-07-23 2000-07-21 Composition for the prevention of muscle fatigue and skeletal muscle adaptation to strenuous exercise

Publications (2)

Publication Number Publication Date
DE60009704D1 true DE60009704D1 (de) 2004-05-13
DE60009704T2 DE60009704T2 (de) 2005-04-14

Family

ID=11406897

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60009704T Expired - Lifetime DE60009704T2 (de) 1999-07-23 2000-07-21 Zusammensetzung zur vorbeugung von muskulärer erschöpfung und zur anpassung von skelettmuskel an intensive körperliche anstrengung

Country Status (21)

Country Link
US (1) US6602512B1 (de)
EP (1) EP1196046B1 (de)
AR (1) AR024820A1 (de)
AT (1) ATE263496T1 (de)
AU (1) AU778647B2 (de)
CA (1) CA2377128C (de)
CZ (1) CZ20023A3 (de)
DE (1) DE60009704T2 (de)
DK (1) DK1196046T3 (de)
ES (1) ES2216931T3 (de)
HU (1) HU228838B1 (de)
IL (1) IL147408A0 (de)
IT (1) IT1306173B1 (de)
MX (1) MXPA02000780A (de)
NO (1) NO20020337L (de)
PL (1) PL204743B1 (de)
PT (1) PT1196046E (de)
SK (1) SK942002A3 (de)
TN (1) TNSN00161A1 (de)
TR (1) TR200200179T2 (de)
WO (1) WO2001006873A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1316998B1 (it) * 2000-03-02 2003-05-26 Sigma Tau Healthscience Spa Composizione per la prevenzione e/o il trattamento degli effetticitotossici indotti dall'uso di agenti immunosoppressori.
US7449451B2 (en) * 2001-08-29 2008-11-11 Premier Micronutrient Corporation Use of multiple antioxidant micronutrients as systemic biological radioprotective agents against potential ionizing radiation risks
US6849613B2 (en) 2001-08-29 2005-02-01 Kedar N. Prasad Multiple antioxidant micronutrients
DE10160485A1 (de) * 2001-12-08 2003-10-02 Degussa Verwendung von Kreatin und/oder einem seiner physiologisch geeigneten Derivate zur Prävention oder Linderung von nicht krankheitsbedingten Beeinträchtigungen und/oder Störungen der Muskelfunktion
DE102004009962A1 (de) * 2004-03-01 2005-09-22 Degussa Ag Verwendung von Guanidin-Verbindungen als physiologisches Stärkungsmittel in Form von Nahrungsergänzungsmitteln, Futtermittelzusätzen, in kosmetischen Zubereitungen und als Pflanzenstärkungsmittel
US20060083793A1 (en) * 2004-09-29 2006-04-20 Gardiner Paul T Nutritional composition for promoting muscle performance and acting as hydrogen (H+) blocker
EP1904070A4 (de) * 2005-07-07 2009-09-02 H3 Formulations Ltd Nahrungsergänzung zur verbesserung der skelettmuskelmasse, verringerung des muskelproteinabbaus, downregulierung von muskel-katabolismuspfaden und verringerung des katabolismus von muskelzellen
GB0606864D0 (en) * 2006-04-05 2006-05-17 Univ Nottingham Increades fatty acid oxidation
WO2008025115A1 (en) * 2006-08-30 2008-03-06 Aplodan Formulations Ltd. Method of increasing intracellular concentrations of phosphate and increasing the force of muscular contractions
US7368441B2 (en) * 2006-08-30 2008-05-06 Aplodan Formulations Ltd. Method of increasing intracellular concentrations of phosphate and increasing the force of muscular contractions
EP2061473A4 (de) * 2006-08-30 2009-11-11 Aplodan Formulations Ltd Erhöhung der atp-verfügbarkeit durch hemmung von creatin-kinase-(ck)-leckage als folge von hochintensiver körperlicher betätigung
US7375097B2 (en) * 2006-08-30 2008-05-20 Aplodan Formulations Ltd. Increasing ATP availability by inhibition of creatine kinase (CK) leakage resulting from high-intensity exercise
US20100124587A1 (en) * 2008-11-17 2010-05-20 Heuer Marvin A Creatine-containing vitamin and mineral composition
US20110105786A1 (en) * 2009-11-02 2011-05-05 Tianjin Tiancheng Pharmaceutical Co., Ltd. Creatinol o-phosphate and synthesis method thereof
WO2012079058A2 (en) 2010-12-10 2012-06-14 Broady Health Sciences, Llc Use of jasmonate to treat bladder dysfunction
BR112016028654A2 (pt) * 2014-06-12 2018-07-10 Lonza Ag método para diminuição de dano muscular esquelético e / ou estresse oxidativo em mamíferos
US10499682B2 (en) 2014-08-25 2019-12-10 New Age Beverage Corporation Micronutrient formulation in electronic cigarettes
US10674746B2 (en) 2015-10-27 2020-06-09 Cytozyme Animal Nutrition, Inc. Animal nutrition compositions and related methods
CN108473384A (zh) 2015-10-27 2018-08-31 细胞酶动物营养品公司 动物营养成分及相关方法
US10888571B2 (en) 2015-12-18 2021-01-12 Lonza Consumer Health Inc. Method and composition for increasing muscle protein synthesis and/or functional strength in mammals

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU518617B2 (en) * 1977-04-29 1981-10-08 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Therapeutic application of acetyl-d, 1-carnitine
IT1124697B (it) 1979-10-26 1986-05-14 Simes Derivati di creatinolo o-fosfato ad azione terapeutica,procedimento per la sua preparazione e relativ-e composizioni farmaceutiche
US6080788A (en) * 1997-03-27 2000-06-27 Sole; Michael J. Composition for improvement of cellular nutrition and mitochondrial energetics
IT1291127B1 (it) * 1997-04-01 1998-12-29 Sigma Tau Ind Farmaceuti Integratore alimentare per soggetti dediti ad intensa e prolungata attivita' fisica
EP0891719A1 (de) * 1997-07-14 1999-01-20 N.V. Nutricia Narungszusammensetzungen mit Gehalt an Methionin
JP2002510604A (ja) 1998-04-02 2002-04-09 アビセナ グループ， インク． クレアチン化合物及び第二物質の組み合わせを含む組成
ES2146555B1 (es) 1999-01-22 2001-03-01 Helsint S A L Empleo de formulaciones a base de fracciones hidrosolubles de phlebodium decumanum (exply-37) y/o polypodium leucotomos como complemento nutricional en la prevencion y reversion del sindrome de sobresfuerzo fisico.

Also Published As

Publication number Publication date
WO2001006873A1 (en) 2001-02-01
HUP0202298A3 (en) 2005-07-28
EP1196046B1 (de) 2004-04-07
PL204743B1 (pl) 2010-02-26
ATE263496T1 (de) 2004-04-15
AU778647B2 (en) 2004-12-16
TR200200179T2 (tr) 2002-06-21
EP1196046A1 (de) 2002-04-17
ITRM990467A0 (it) 1999-07-23
AU6468700A (en) 2001-02-13
MXPA02000780A (es) 2002-08-20
DE60009704T2 (de) 2005-04-14
HU228838B1 (en) 2013-06-28
IL147408A0 (en) 2002-08-14
SK942002A3 (en) 2002-05-09
AR024820A1 (es) 2002-10-23
PL352683A1 (en) 2003-09-08
DK1196046T3 (da) 2004-08-02
PT1196046E (pt) 2004-08-31
CZ20023A3 (cs) 2002-06-12
ES2216931T3 (es) 2004-11-01
NO20020337L (no) 2002-03-22
TNSN00161A1 (fr) 2005-11-10
ITRM990467A1 (it) 2001-01-23
NO20020337D0 (no) 2002-01-22
CA2377128A1 (en) 2001-02-01
US6602512B1 (en) 2003-08-05
HUP0202298A2 (en) 2002-10-28
CA2377128C (en) 2009-09-22
IT1306173B1 (it) 2001-05-30

Similar Documents

Publication Publication Date Title
DE60009704D1 (de) Zusammensetzung zur vorbeugung von muskulärer erschöpfung und zur anpassung von skelettmuskel an intensive körperliche anstrengung
ATE243494T1 (de) Orale zubereitung zur bekämpfung von mundgeruch
ID20910A (id) Celana latihan sekali pakai
DE60138711D1 (de) Antikörper gegen il-12, zusammensetzungen, verfahren und verwendungen
DE60017477D1 (de) Modifiziertes Dienelastomer und seine Herstellung
DE60001107T2 (de) Sichere und handliche hinweisanordung
DE60307766D1 (de) Gewürzmittel und Verfahren zu seiner Herstellung
DE60232867D1 (de) Piezoelektrisches porzellan und verfahren zu seine
EE200100653A (et) Indolüülpiperidiinühendid, nende valmistamismeetod, kompositsioon ja nende kasutamine
DE60034754D1 (de) Resistzusammensetzung und Musterübertragungsverfahren
DE10082299T1 (de) Wellenformgenerator und Prüfvorrichtung
IL164695A0 (en) Method and composition for reducing pain using oncolytic viruses
DE60044930D1 (de) Resistzusammensetzung und Musterübertragungsverfahren
DE60105754D1 (de) Polyimid und polyamidsäure
DK1061955T3 (da) Polynukleotidsammensætning, fremstillingsmetode og anvendelse deraf
AU2002360531A8 (en) Methods and compositions to treat cardiovascular disease using 1419, 58765 and 2201
DE50004114D1 (de) Substituierte pyrrol-mannichbasen zur bekämpfung von schmerzen und allergischen reaktionen
AU2002237733A1 (en) Methods and compositions relating to muscle specific sarcomeric calcineurin-binding proteins (calsarcins)
DE29619251U1 (de) Trainingsgerät zur Stärkung der Nacken- und Rückenmuskulatur
FI991050A0 (fi) Lateksikoostumukset ja niiden valmistamismenetelmä
EP1450666A4 (de) Verfahren und zusammensetzungen zur behandlung von herz-kreislauf-erkrankungen unter verwendung von 139,258,1261,1486,2398,2414,7660,8587,10183,10550,12680,17921,32248,60489 oder 93804
DE69811175D1 (de) Crosslauf-Übungsgerät
GB2360000B (en) Improvements relating to exercising devices
AP2000001921A0 (en) Resistance in plants to infection by ssdna virus using inoviridae virus ssdna-binding protein compositions and methods of use
NO985954D0 (no) Muskeltreningsutstyr

Legal Events

Date Code Title Description
8332 No legal effect for de
8370 Indication related to discontinuation of the patent is to be deleted
8364 No opposition during term of opposition